Responding to the National CER Agenda: Evolving Data Sources and Analytics

Hosted by The Lewin Group Center for Comparative Effectiveness Research

On Tuesday, June 15, 2010, The Lewin Center for CER will host Carolyn Clancy, MD, Director, Agency for Healthcare Research and Quality (AHRQ) as the morning keynote speaker and David Blumenthal, MD, Chairman, Office of the National Coordinator for Health Information Technology, as the lunch keynote speaker at an invitation-only symposium with senior government officials, policy and thought leaders, and academics focused on comparative effectiveness research (CER).

The symposium addresses the role that data will play in the implementation of CER projects. Speakers and panels will discuss topics including uses of new data sources in CER and ways to link claims data to outcomes; the limits of randomized clinical trials in CER; propensity scoring, selection bias, and decomposition analysis; and HIPAA constraints, privacy and confidentiality.

Check back following the event for a record of the proceedings and powerpoint slides from the presentations.

Confirmed speakers include:

Daniel Barth-Jones, Assistant Professor of Clinical Epidemiology, Columbia University Mailman School of Public Health
Anirban Basu, Assistant Professor Department of Medicine, University of Chicago
David Blumenthal, MD, Chairman, Office of the National Coordinator for Health Information Technology
Carolyn Clancy, M.D., Director, Agency for Healthcare Research and Quality (AHRQ)
William Crown, President, i3 Innovus
Taylor Dennen, Managing Director, The Lewin Group Center for Comparative Effectiveness Research
Mary L Durham, PhD, Senior Investigator and Director, The Center for Health Research, Kaiser Foundation Hospitals
Josh Gagne, MD, Dept. of Medicine, Brigham & Women's Hospital
Clifford Goodman, Vice President, The Lewin Group Center for Comparative Effectiveness Research
Sheldon Greenfield, MD, Executive Director, Health Policy Research Institute, University of California, Irvine
Michael S Lauer, MD, Director, Division of Cardiovascular Sciences (DCVS), National Heart, Lung, and Blood Institute (NHLBI), NIH
Deven McGraw, Director, Center for Democracy and Technology
Eleanor Perfetto, Senior Director, Reimbursement & Regulatory Affairs, Pfizer
John Seeger, Chief Scientist, i3 Drug Safety
Adindu Uzoma, Senior Fellow, Ingenix
Marcy Wilder, Partner, Hogan Lovells